Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Free healthy groceries delivered to your door may help lower blood pressure

NCT ID NCT05393232

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jul 09, 2026 · Updated 4 times

Summary

This study tests whether providing home-delivered DASH diet groceries, with help from a dietitian, can lower blood pressure in Black adults who already take medication for hypertension and live in areas with limited access to healthy food. About 150 participants will receive weekly groceries for 12 weeks. The goal is to see if this approach can improve blood pressure control in communities affected by food deserts.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
DASH diet groceries with dietitian assistance
What this could lead to
If it works, this could show that providing healthy groceries can help control blood pressure in communities with limited access to healthy food.
What could go wrong
This is a small, early-stage trial with only 150 participants, so results may not apply to everyone. The effect on blood pressure may be modest or temporary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

176 people

The number who actually took part.

Started

Oct 2022

Finished

May 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

INCLUSION: * Self-reported/self-identified as Black or African American * Resting systolic blood pressure of 120 to \<150 mm Hg and diastolic blood pressure \<100 mm Hg * Active treatment with medications intended for hypertension treatment within the last 6 months at stable doses * Residence in communities identified as Boston area food deserts: Brighton, Chelsea, Dorchester, East Boston, Everett, Hyde Park, Jamaica Plain, Malden, Mattapan, Revere, Roslindale, Roxbury, or Winthrop * Able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 12-week period * Have access to refrigeration, cooking appliances, and Wi-Fi/cellular service * Have access to mobile device or computer to be able to conduct grocery orders via video conference or by phone * Willing and able to complete required measurement procedures EXCLUSION: Laboratory Exclusions: * Serum potassium ≥5.0 mmol/L or \<3.5 mmol/L * Estimated glomerular filtration rate (eGFR) \<30 mL/min per 1.73 m\^2 by the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation * Hemoglobin A1c ≥6.5% Medication Exclusions: * Unstable doses of medications that lower blood pressure or medications intended for hypertension treatment (including antihypertensives taken for non-hypertension purposes) within the last 6 months * Unstable doses (i.e. a change in the 2 months prior to screening or randomization) of the following: * Sodium-glucose co-transporter 2 (SGLT2) inhibitors * Stimulants * Inhaled or oral medications for asthma or chronic obstructive pulmonary disease (COPD) * Hormone replacement therapy or thyroid hormone * Weight-increasing psychotropic agents, including antipsychotic agents, lithium, and mirtazapine * Use of any of the following medications: * Potassium supplement, except if part of a multivitamin * Warfarin (Coumadin) * Chronic oral corticosteroid (intermittent use is okay) * Weight loss medications (including GLP-1 receptor agonists) * Unwillingness to keep same dose of vitamin, mineral, and botanical supplements * Any medication not compatible with participation as determined by the investigators Physical Exclusions: * Systolic blood pressure ≥150 mm Hg or diastolic blood pressure ≥100 mm Hg * Body weight \>420 pounds * Arm circumference \>50cm * Weight loss or gain of \>5.0% of body weight during prior 2 months Medical History Exclusions: * Type 1 or Type 2 Diabetes defined as a hemoglobin A1c ≥6.5% or diabetes treatment * Active cardiovascular disease or any event in the prior 6 months, including coronary artery bypass grafting (CABG), percutaneous transluminal coronary angioplasty (PTCA), myocardial infarction (MI), cerebrovascular accident (CVA), or congestive heart failure (CHF) exacerbation requiring hospital admission * Cancer diagnosis or treatment in the last 2 years (non-melanoma skin cancer or localized breast or prostate or bladder cancer not requiring systemic therapy is acceptable) * Active inflammatory bowel disease, bowel resection, malabsorptive syndrome, pancreatitis (episode within past year), or history of bariatric surgery * Pregnancy or lactation or planned pregnancy * Any emergency department (ED) visit for asthma or chronic obstructive pulmonary disease (COPD) in the last 6 months * Any other serious illness or condition not compatible with participation as determined by the investigators Lifestyle and Other Exclusions: * Significant food allergies, preferences, intolerances, or dietary requirements that would interfere with diet adherence * Consumption of more than 14 alcoholic drinks per week or consumption of more than 6 drinks on one or more occasion per week * Active substance use disorder that would interfere with participation * Extreme food insecurity * Participation in or planning to start weight loss program * Current participation in another clinical trial that could interfere with the study protocol * Anticipated change in residence prior to the end of the study * Families with more than 6 adults at dinner time (children are considered to be half an adult) * Investigator discretion

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center - Clinical Research Center

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.